Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001123292-23-000114
Filing Date
2023-09-12
Accepted
2023-09-12 16:30:42
Documents
2
Group Members
BLUE HORIZON ENTERPRISE LTD.EZBON INTERNATIONAL LTDMONTRAGO TRUSTEES LTD

Document Format Files

Seq Description Document Type Size
1 akero13g.htm SC 13G/A 259907
2 image00004.jpg GRAPHIC 41595
  Complete submission text file 0001123292-23-000114.txt   318815
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Subject) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91047 | Film No.: 231250482
SIC: 2834 Pharmaceutical Preparations

Mailing Address 195 ARCH. MAKARIOS III AVE. NEOCLEOUS HOUSE LIMASSOL G4 3030
Business Address 195 ARCH. MAKARIOS III AVE. NEOCLEOUS HOUSE LIMASSOL G4 3030 3-572-511-0165
Skorpios Trust (Filed by) CIK: 0001869333 (see all company filings)

EIN.: 000000000 | State of Incorp.: G4 | Fiscal Year End: 1231
Type: SC 13G/A